Genetic and Acquired Determinants of Individual Variability of Response to Antiplatelet Drugs
- 26 August 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (8) , 910-911
- https://doi.org/10.1161/01.cir.0000088843.52678.8a
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel TrialCirculation, 2003
- Clopidogrel for Coronary StentingCirculation, 2003
- Aspirin and Clopidogrel in Acute Coronary SyndromesArchives of internal medicine (1960), 2003
- Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: Do we need more aggressive dosing regimens in unstable angina?Catheterization and Cardiovascular Interventions, 2003
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet AggregationCirculation, 2003
- Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet actionJournal of Vascular Surgery, 2002
- Cyclooxygenase Inhibitors and the Antiplatelet Effects of AspirinNew England Journal of Medicine, 2001
- Common variations in platelet glycoproteins: pharmacogenomic implicationsPharmacogenomics, 2001
- CONTROVERSIES IN HEART FAILURECardiology Clinics, 2001
- Antiatherothrombotic Properties of StatinsJAMA, 1998